|
Influenza Congress USA 2010 is known as the North America’s most prominent influenza congress. Talking about the adult vaccine market, the influenza vaccine is developing as the fastest growing segment. As the disease is emerging as a crucial threat, the governments & international organizations are raising awareness about the successful vaccines & antivirals to defend their populations. The congress will be helpful to learn about the major drivers including cost effectiveness, capacity and adaptability, which are influencing the development of influenza vaccines & related therapies. Influenza Congress USA will facilitate the attendees to achieve precious insight and accelerate their organization at the head of influenza planning and development.
- Pandemic influenza A (H1N1) overview
- Pandemic preparedness
- Antivirals
- Adjuvants
- Alternatives to traditional egg-based vaccines
- Production, manufacturing & capacity
- Collaboration & partnerships
Visitor Profile
- Pharma vaccine & antiviral manufacturers
- Biotechs
- Government, public health & NGOs
- Research institutes & academia
- Contract service organizations
- Venture capitalists
- Logistics & cold chain supply
- Equipment manufacturers
- Drug discovery & delivery platforms
- Management, technology & regulatory consultants
Organizer
Terrapinn